Advertisement
U.S. Markets open in 6 hrs 57 mins
S&P Futures
6,006.25 +2.50 (+0.04%) Dow Futures
43,914.00 +4.00 (+0.01%) Nasdaq Futures
21,228.75 +4.00 (+0.02%) Russell 2000 Futures
2,395.50 -0.20 (-0.01%) Crude Oil
71.74 -0.62 (-0.86%) Gold
2,690.60 -15.20 (-0.56%)
CytomX Therapeutics Inc (6C1.BE)
Berlin - Berlin Delayed Price. Currency in EUR
Follow
As of 08:09AM CET. Market open.
| Previous Close | 0.9260 |
| Open | 1.0590 |
| Bid | 0.9300 x N/A |
| Ask | 1.1890 x N/A |
| Day's Range | 1.0590 - 1.0590 |
| 52 Week Range | 0.8780 - 4.5320 |
| Volume | |
| Avg. Volume | 15 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Nov 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ZacksCytomX Therapeutics (CTMX) Q3 Earnings and Revenues Top Estimates
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of 143.75% and 76.70%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press Finance
CytomX Therapeutics: Q3 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. AP) — CytomX Therapeutics Inc. CTMX) on Thursday reported third-quarter profit of $5.8 million.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.